N-Acetyltransferase 1 (NAT1) Antibody
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Description
This product is currently in development. The lead time for this product may be several months. Please contact us at
Documents del producto
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | N-Acetyltransferase 1 (NAT1) |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Purification | Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography. |
| Size 1 | 1 ml |
| Form | Liquid |
| Tested Applications | WB, IHC, IF/ICC |
| Buffer | 0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol. |
| Availability | Please enquire. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Background | Antibody anti-NAT1 |
| Status | RUO |
Descripción
Related Products
NAT1 antibody
Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N-or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens.
Ver ProductoNAT1 antibody
Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N-or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens.
Ver ProductoNAT1 antibody
Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Catalyzes the N-or O-acetylation of various arylamine and heterocyclic amine substrates and is able to bioactivate several known carcinogens.
Ver Producto